7.04MMarket Cap-295P/E (TTM)
2.0300High1.8180Low62.09KVolume1.9300Open1.9700Pre Close118.62KTurnover2.22%Turnover RatioLossP/E (Static)3.47MShares11.000052wk High1.20P/B5.67MFloat Cap1.350052wk Low--Dividend TTM2.80MShs Float528.5000Historical High--Div YieldTTM10.76%Amplitude1.3500Historical Low1.9100Avg Price1Lot Size
TFF Pharmaceuticals Stock Forum
📊⚡️📊
TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery
TFF Pharmaceuticals (Nasdaq: TFFP) announces positive preclinical data published in the Journal of Drug Delivery Science and Technology, validating its Thin Film Freezing (TFF) technology as a superior approach for formulating dry powders for pulmonary drug delivery. The study compared TFF inhalational dry powders with jet-milling and spray-drying...
5 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
TFF Pharmaceuticals Announced Its New Partnership With Emory University And The Biomedical Advanced Research And Development Authority To Develop A Dry Powder Inhaled Mrna-based Treatment For Influenza And Covid
TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization
TFF-dry powder HA antigen vaccine candidates induced neutralizing antibody titers in ferrets against H1 and H3 influenza strains
Ongoing funded work to assess additional influenza strains
FORT WORTH, Texas, Sept. 10, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (NASDAQ:TFFP) (the "Company" or "TF...
TFF Pharmaceuticals Provides Continued Positive Outcomes From Tacrolimus Inhalation Powder (TFF Tac) Phase 2 Trial for the Prevention of Lung Transplant Rejection
TFF Pharmaceuticals, Cleveland Clinic Partner To Advance Multiple Multivalent Universal Influenza Vaccines To Protect Against Seasonal, Pandemic Viruses Into Preclinical Testing
No comment yet